Dr Boreham's Crucible: Imugene - FNArena.com
Tim Boreham highlights the prospects for cancer treatment biotech Imugene
Source: fnarena.com
Kim Drapkin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Kim Drapkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Kim Drapkin Today - Breaking & Trending Today
Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update
11.08.2023 - Initial Clinical Data Readout from Ongoing Phase 1/2 Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Anticipated by End of 2023 Received $5 Million Research and Development Collaboration Milestone Payment from Merck Cash Runway into ...
Source: wallstreet-online.de
Oncology stocks advance at pace despite lukewarm market
The oncology sector – like most of the healthcare sector – has been struggling post-COVID boom, faltering in the face of a tight financial market reluctant...
Source: proactiveinvestors.com.au
Jounce Therapeutics : NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION - Form 8-K
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH... | March 27, 2023
Source: marketscreener.com
Jounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. ... | March 27, 2023
Source: marketscreener.com